642 results on '"Tanizawa Y"'
Search Results
2. 10~Mb/s quantum key distribution
3. Cambridge quantum network
4. SA71 Validation Study of Algorithms to Identify Cancer Metastasis/Recurrence in Patients With High-Risk HR+/HER2- Early Breast Cancer (EBC) Using Japan Nationwide Hospital-Based Databases Owned By National Hospital Organization
5. P4-5 Patient characteristics and treatment patterns in patients with Mantle cell lymphoma in Japan: a real-world study.
6. P1134: OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA POST-CBTK INHIBITOR THERAPY IN THE UNITED STATES AND JAPAN: A STUDY OF TWO REAL-WORLD DATABASES
7. Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study
8. Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus
9. Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy
10. Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice
11. Risk factors for para-aortic nodes metastasis: Preliminary analysis from far Eastern and Western centers
12. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects
13. Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF
14. Overexpression of dominant negative mutant hepatocyte nuclear factor (HNF)-1α inhibits arginine-induced insulin secretion in MIN6 cells
15. Pioglitazone induces islet adrenomedullin expression and attenuates beta-cell ER stress: 151
16. The cross sectional analysis on genetic and clinical features of Japanese patient with Wolfram syndrome Speaker: Prof. Kimie Matsunaga (Japan): OP4-1
17. Genetic and acquired factors determining natural history of type 2 diabetes mellitus: SP2-3
18. Cytomegalovirus ventriculoencephalitis in a reduced- intensity conditioning cord blood transplant recipient
19. Distinct thermal migration behaviors in response to different thermal gradients in Caenorhabditis elegans
20. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets
21. A human pancreatic islet inwardly rectifying potassium channel: cDNA cloning, determination of the genomic structure and genetic variations in Japanese NIDDM patients
22. Successful engraftment of the second reduced-intensity conditioning cord blood transplantation (CBT) for a patient who developed graft rejection and infectious complications after the first CBT for AML
23. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects
24. Donor cell-derived acute myeloid leukemia after unrelated umbilical cord blood transplantation
25. Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients
26. Molecular screening of the glucokinase gene in familial Type 2 (non-insulin-dependent) diabetes mellitus
27. Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning
28. Three dimensional analysis of the local structure of Cu on TiO2(110) by in-situ polarization-dependent total-reflection fluorescence XAFS
29. Two microsatellite repeat polymorphisms flanking opposite ends of the human glucokinase gene: use in haplotype analysis of Welsh Caucasians with Type 2 (non-insulin-dependent) diabetes mellitus
30. Linkage analysis of the glucokinase locus in familial Type 2 (non-insulin-dependent) diabetic pedigrees
31. Isolation, Characterization, and Mapping of Human Islet Transcription Factors
32. Linkage of type 2 diabetes to the glucokinase gene
33. Prediction of S-1 adjuvant chemotherapy efficacy in stage II/III gastric cancer treatment based on comprehensive gene expression analysis
34. Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms
35. The optimal extent of lymph node dissection for Siewert type II adenocarcinoma of the esophagogastric junction
36. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria
37. Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione
38. Narrow band and energy selectable plasma cathode for multistage laser wakefield acceleration
39. Factors predicting early postpartum glucose intolerance in Japanese women with gestational diabetes mellitus: decision‐curve analysis
40. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus
41. Quantum key distribution with hacking countermeasures and long term field trial
42. Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading
43. 821P - Prediction of S-1 adjuvant chemotherapy efficacy in stage II/III gastric cancer treatment based on comprehensive gene expression analysis
44. New approach to gastric cancer classification based on TP53 mutation
45. Genetic analysis of gastric cancer with distinctive family history
46. Efficacy of staging laparoscopy for type 4 and large type 3 gastric cancer
47. 59. Efficacy of surgical treatment for responders to chemotherapy for gastric cancer with para-aortic lymph node metastasis
48. A genomic approach to selecting robust and versatile SNP sets from next-generation sequencing data for genome-wide association study in citrus cultivars
49. Graphene oxide reduced through chemical and biological processes
50. Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in J apanese patients with type 2 diabetes: a randomized, open‐label, phase III , non‐inferiority study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.